// App-Quantinova.ai

2813 : Growth Suppressing Activity of Lhx2 in Human T Cell Acute Lymphoblastic Leukemia (T-ALL)-Derived Cells and Large-Scale Screening of a Lead Compounds Targeting T-ALL

Researchers

Presenter

  • Noritaka Kagaya

Principal Investigators

  • Miho Izumikawa

  • Kenji Kitajima

  • Kazuo Shin-ya

  • Takahiko Hara

  • Kyoko Watakabe-Inamoto

  • Yuho Najima

  • Noriko Doki

  • Takeshi Kobayashi

  • Kazuhiko Kakihana

  • Susumu Goyama

  • Toshio Kitamura

  • Kazuteru Ohashi

Medical Centers

  • Department of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

  • Graduate School of Biomedical Science, Tokyo Medical and Dental University, Tokyo, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.

  • Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

  • Solid malignancies

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved